NOVN:SWX
Novartis AG
CHF 113.92
arrow_upward
+1.68%(+1.88) 1D
Sep 14, 5:31:45 PM GMT+2 · CHF
search
All symbols
1D
5D
1M
6M
YTD
1Y
5Y
MAX
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for NOVN...
Open
CHF 113.20
High
CHF 116.04
Low
CHF 113.18
Mkt. cap
232.83B
Avg. vol.
2.63M
Volume
3.03M
Dividend
3.25%
Quarterly dividend
CHF 0.93
Ex-dividend date
Mar 10, 2026
P/E ratio
21.08
52-wk high
CHF 132.68
52-wk low
CHF 96.03
EPS
CHF 5.40
Shares outstanding
2.03B
No. of employees
75K
Open
CHF 113.20
High
CHF 116.04
Low
CHF 113.18
Mkt. cap
232.83B
Avg. vol.
2.63M
Volume
3.03M
Dividend
3.25%
Quarterly dividend
CHF 0.93
Ex-dividend date
Mar 10, 2026
P/E ratio
21.08
52-wk high
CHF 132.68
52-wk low
CHF 96.03
EPS
CHF 5.40
Shares outstanding
2.03B
No. of employees
75K
News stories
From web sources and news partners
ad-hoc-news.de
·
12 hours ago
Novartis stock recovers after trial setbacks as analysts lift earnings outlook
The Motley Fool
·
14 hours ago
Novartis Just Shook Up a Multibillion-Dollar Drug Race. What It Means for Eli Lilly Stock.
ad-hoc-news.de
·
18 hours ago
Novartis stock heads into the open after a 0.4 percent dip
TradingView
·
19 hours ago
Weekly Recap: Trial failures and ~10% share drop, weaker 2030s outlook
Profile
Novartis AG is a Swiss multinational pharmaceutical corporation based in Basel, Switzerland. Novartis is one of the largest pharmaceutical companies in the world and was the eighth largest by revenue in 2024.
Novartis manufactures the drugs clozapine, diclofenac, carbamazepine, valsartan, imatinib mesylate, cyclosporine, letrozole, methylphenidate, terbinafine, deferasirox, and others.
Novartis was formed in 1996 by the merger of Ciba-Geigy and Sandoz. It was considered the largest corporate merger in history during that time. The pharmaceutical and agrochemical divisions of both companies formed Novartis as an independent entity. The name Novartis was based on the Latin terms, novae artes.
After the merger, other Ciba-Geigy and Sandoz businesses were sold, or, like Ciba Specialty Chemicals, spun off as independent companies. The Sandoz brand disappeared for three years, but was revived in 2003 when Novartis consolidated its generic drugs businesses into a single subsidiary and named it Sandoz. Wikipedia
About Novartis AG
CEOVasant Narasimhan
Employees75.3K
FoundedMar 7, 1996
HeadquartersBasel, Basel City, Switzerland
SectorPharmaceutical industry
Websitenovartis.com